Roivant Sciences(DE:87S)
€35.47+0.83 (+10.77%)
DE:87S
Roivant Sciences financials statements
€35.47
At close:+0.83 (+10.77%)
Roivant Sciences (87S) Ratios
2 Followers
Roivant Sciences Ratios
DE:87S's free cash flow for Q2 2026 was $594.21M. For the 2026 fiscal year, DE:87S's free cash flow was decreased by $-208.00K and operating cash flow was $594.42M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 |
| Quick Ratio | 18.37 | 33.47 | 25.10 | 6.59 | 11.64 |
| Cash Ratio | 5.05 | 18.17 | 24.50 | 6.15 | 11.18 |
| Solvency Ratio | -0.71 | -0.63 | 5.65 | -1.27 | -1.60 |
| Operating Cash Flow Ratio | -2.67 | -5.62 | -2.87 | -3.10 | -3.68 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -85.29 | -63.77 | -20.71 | 0.00 |
| Net Current Asset Value | $ 4.75B | $ 4.75B | $ 5.96B | $ 1.02B | $ 1.62B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.07 | 0.20 | 0.11 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.08 | 0.42 | 0.17 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.08 | 0.29 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.07 | 0.24 | 0.11 |
| Financial Leverage Ratio | 1.26 | 1.16 | 1.21 | 2.06 | 1.56 |
| Debt Service Coverage Ratio | 0.00 | -72.72 | -17.62 | -17.23 | -129.41 |
| Interest Coverage Ratio | 0.00 | 0.00 | 129.31 | -42.02 | -191.97 |
| Debt to Market Cap | 0.00 | 0.00 | 0.05 | 0.08 | 0.06 |
| Interest Debt Per Share | 0.15 | 0.14 | 0.68 | 0.71 | 0.43 |
| Net Debt to EBITDA | 5.02 | 3.92 | 7.52 | 1.01 | 1.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.44% | 96.86% | 95.11% | 78.58% | 83.78% |
| EBIT Margin | -3203.12% | -2346.02% | -2521.71% | -1953.11% | -1658.12% |
| EBITDA Margin | -3162.59% | -2297.59% | -2454.35% | -1922.34% | -1647.39% |
| Operating Profit Margin | -15560.57% | -3833.27% | 13746.93% | -1917.95% | -2444.82% |
| Pretax Profit Margin | -3203.12% | -2346.02% | 13963.43% | -1998.75% | -1670.85% |
| Net Profit Margin | -3629.19% | -591.96% | 13294.18% | -1646.59% | -1528.89% |
| Continuous Operations Profit Margin | -4817.28% | -2511.84% | 13897.70% | -2007.22% | -1671.52% |
| Net Income Per EBT | 113.30% | 25.23% | 95.21% | 82.38% | 91.50% |
| EBT Per EBIT | 20.58% | 61.20% | 101.57% | 104.21% | 68.34% |
| Return on Assets (ROA) | -5.25% | -3.16% | 60.21% | -42.23% | -32.70% |
| Return on Equity (ROE) | -6.62% | -3.67% | 72.86% | -87.15% | -51.01% |
| Return on Capital Employed (ROCE) | -23.68% | -21.06% | 64.65% | -55.51% | -56.30% |
| Return on Invested Capital (ROIC) | -23.63% | -21.02% | 64.15% | -54.17% | -56.03% |
| Return on Tangible Assets | -5.25% | -3.16% | 61.39% | -44.95% | -32.70% |
| Earnings Yield | -1.56% | -2.35% | 53.24% | -19.18% | -25.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.01 | 0.00 | 0.40 | 1.63 | 8.21 |
| Payables Turnover | 0.07 | 0.04 | 0.03 | 0.35 | 0.26 |
| Inventory Turnover | 0.00 | 0.00 | 0.05 | 4.75 | 0.00 |
| Fixed Asset Turnover | 0.09 | 0.29 | 0.50 | 0.66 | 0.64 |
| Asset Turnover | 0.00 | 0.01 | 0.00 | 0.03 | 0.02 |
| Working Capital Turnover Ratio | 0.00 | 0.01 | 0.01 | 0.04 | 0.03 |
| Cash Conversion Cycle | 28922.40 | -9492.00 | -3178.89 | -750.81 | -1363.41 |
| Days of Sales Outstanding | 34035.81 | 0.00 | 924.00 | 224.22 | 44.44 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 8046.66 | 76.76 | 0.00 |
| Days of Payables Outstanding | 5113.41 | 9492.00 | 12149.55 | 1051.79 | 1407.85 |
| Operating Cycle | 34035.81 | 0.00 | 8970.66 | 300.98 | 44.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.08 | -1.16 | -0.98 | -1.18 | -1.01 |
| Free Cash Flow Per Share | -1.09 | -1.16 | -0.98 | -1.20 | -1.04 |
| Dividend Paid and CapEx Coverage Ratio | -91.41 | -182.53 | -103.67 | -66.46 | -38.87 |
| Capital Expenditure Coverage Ratio | -91.41 | -182.53 | -553.74 | -66.46 | -38.87 |
| Operating Cash Flow Coverage Ratio | -6.98 | -8.38 | -1.53 | -1.75 | -2.39 |
| Operating Cash Flow to Sales Ratio | -90.84 | -28.89 | -23.39 | -13.76 | -12.26 |
| Free Cash Flow Yield | -3.95% | -11.53% | -9.38% | -16.27% | -21.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -64.42 | -42.04 | 1.88 | -5.21 | -3.91 |
| Price-to-Sales (P/S) Ratio | 2326.88 | 251.93 | 249.73 | 85.84 | 59.84 |
| Price-to-Book (P/B) Ratio | 4.25 | 1.56 | 1.37 | 4.54 | 2.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -25.34 | -8.67 | -10.66 | -6.14 | -4.76 |
| Price-to-Operating Cash Flow Ratio | -25.61 | -8.72 | -10.68 | -6.24 | -4.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.81 | 0.40 | -0.00 | -0.41 | -0.58 |
| Enterprise Value Multiple | -68.55 | -7.05 | -2.66 | -3.45 | -1.68 |
| Enterprise Value | 17.91B | 4.70B | 2.13B | 4.06B | 1.53B |
| EV to EBITDA | -68.55 | -7.05 | -2.66 | -3.45 | -1.68 |
| EV to Sales | 2168.07 | 161.91 | 65.21 | 66.33 | 27.71 |
| EV to Free Cash Flow | -23.61 | -5.57 | -2.78 | -4.75 | -2.20 |
| EV to Operating Cash Flow | -23.87 | -5.60 | -2.79 | -4.82 | -2.26 |
| Tangible Book Value Per Share | 7.63 | 7.15 | 8.06 | 2.05 | 3.08 |
| Shareholders’ Equity Per Share | 6.52 | 6.46 | 7.62 | 1.62 | 2.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.50 | -0.07 | 0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.01 | 0.04 | 0.04 | 0.09 | 0.08 |
| Net Income Per Share | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 |
| Tax Burden | 1.13 | 0.25 | 0.95 | 0.82 | 0.92 |
| Interest Burden | 1.00 | 1.00 | -5.54 | 1.02 | 1.01 |
| Research & Development to Revenue | 82.54 | 18.95 | 13.45 | 8.57 | 8.74 |
| SG&A to Revenue | 73.91 | 20.36 | 12.72 | 9.80 | 14.02 |
| Stock-Based Compensation to Revenue | 41.91 | 9.95 | 6.10 | 3.55 | 10.22 |
| Income Quality | 1.89 | 2.35 | -0.18 | 0.76 | 0.73 |
Currency in USD
